Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-013712
Filing Date
2025-05-19
Accepted
2025-05-19 18:47:00
Documents
1
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 form4-05192025_100556.html 4  
1 form4-05192025_100556.xml 4 6710
  Complete submission text file 0001415889-25-013712.txt   8134
Mailing Address C/O INNOVIVA, INC. 2000 SIERRA POINT PARKWAY, SUITE 500 BRISBANE CA 94005
Business Address
FRIEDMAN CATHY (Reporting) CIK: 0001411874 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 25965589

Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)